Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DYANAVEL ® XR safely and effectively. See full prescribing information for DYANAVEL XR . DYANAVEL ® XR (amphetamine) extended-release oral suspension , CII DYANAVEL ® XR (amphetamine) extended-release tablets, for oral use, CII Initial U.S. Approval: 1 960
Medication labelWhy this: Advisory · dailymed-prescription
DYANAVEL XR is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies (14)]. Limitations of Use The use of DYANAVEL XR is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.5), Use in Specific Populations (8.4)].
- generic_name
- amphetamine
- product_names
- amphetamine
- ndc
- 24478-102, 24478-106, 24478-108, 24478-109, 24478-110, 24478-102-01, 24478-102-02, 24478-106-01, 24478-108-01, 24478-109-01, 24478-110-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en